Charity Navigator, America’s largest independent evaluator of charities, has awarded a four-star rating to the Diabetes Research Institute Foundation, the highest rating possible from this respected charity oversight organization. The DRI Foundation has received the “Exceptional” grade for exceeding industry standards and outperforming most charities in its cause area.
Charity Navigator works to help charitable givers make intelligent giving decisions by providing information on more than two thousand charities and by evaluating their financial health. It calculates each charity’s score based upon several broad criteria, including how much is spent per dollar raised, what percentage of funds goes to programs vs. administrative and fund-raising expenses, and the organization’s long-term financial health. It then assigns a rating from one to four, with four being the best rating.
“We applaud your charitable efforts and congratulate you for receiving a four-star rating from Charity Navigator. Receiving four out of a possible four stars indicates that your organization excels, as compared to other charities in America, in the area of strong fiscal management,” stated Trent Stamp, executive director of Charity Navigator. “The Diabetes Research Institute’s supporters can be confident in your efforts to maximize the impact of their donations.”
“It is an honor to receive this distinction for our philanthropic efforts. Over the years, we have gone to great lengths to meet our fiscal responsibility, and we are pleased that Charity Navigator has recognized our diligence in adhering to strict financial accountability. We will strive to maintain the high standards set forth by Charity Navigator, and continue to earn the trust and respect of our donors,” said DRI Foundation President and Chief Executive Officer Robert A. Pearlman.
To view the Diabetes Research Institute Foundation’s rating page, please visit the Charity Navigator website.
The Diabetes Research Institute, a center of excellence at the University of Miami Miller School of Medicine, is a recognized world leader in cure-focused research. Since its inception in the early 1970s, the DRI has made significant contributions to the field of diabetes research, pioneering many of the techniques used in islet transplantation. From innovations in islet isolation and transplant procedures to advances in cell biology and immunology, the DRI is now harnessing the power of emerging technologies to develop new cell-based therapies to restore insulin production. For the millions of families already affected by diabetes who are looking to the world of science for answers, the Diabetes Research Institute is the best hope for a cure. For more information, call 1-800-321-3437.